180 related articles for article (PubMed ID: 32275061)
21. RET mutations in human disease.
Pasini B; Ceccherini I; Romeo G
Trends Genet; 1996 Apr; 12(4):138-44. PubMed ID: 8901418
[TBL] [Abstract][Full Text] [Related]
22. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.
Moore SW; Zaahl M
J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359
[TBL] [Abstract][Full Text] [Related]
23. The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease.
Carniti C; Belluco S; Riccardi E; Cranston AN; Mondellini P; Ponder BA; Scanziani E; Pierotti MA; Bongarzone I
Am J Pathol; 2006 Apr; 168(4):1262-75. PubMed ID: 16565500
[TBL] [Abstract][Full Text] [Related]
24. A Novel Zebrafish ret Heterozygous Model of Hirschsprung Disease Identifies a Functional Role for mapk10 as a Modifier of Enteric Nervous System Phenotype Severity.
Heanue TA; Boesmans W; Bell DM; Kawakami K; Vanden Berghe P; Pachnis V
PLoS Genet; 2016 Nov; 12(11):e1006439. PubMed ID: 27902697
[TBL] [Abstract][Full Text] [Related]
25. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
26. Correlation between multiple RET mutations and severity of Hirschsprung's disease.
Ishii K; Doi T; Inoue K; Okawada M; Lane GJ; Yamataka A; Akazawa C
Pediatr Surg Int; 2013 Feb; 29(2):157-63. PubMed ID: 23114404
[TBL] [Abstract][Full Text] [Related]
27. [Mutations of RET proto-oncogene in Hirschsprung disease].
Lyonnet S; Edery P; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékéte C; Ponder BA; Munnich A
C R Acad Sci III; 1994 Apr; 317(4):358-62. PubMed ID: 8000915
[TBL] [Abstract][Full Text] [Related]
28. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
Camacho CP; Hoff AO; Lindsey SC; Signorini PS; Valente FO; Oliveira MN; Kunii IS; Biscolla RP; Cerutti JM; Maciel RM
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1393-8. PubMed ID: 19169500
[TBL] [Abstract][Full Text] [Related]
29. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.
Nakao KT; Usui T; Ikeda M; Mori Y; Yamamoto T; Kawashima ST; Nanba K; Yuno A; Tamanaha T; Tagami T; Naruse M; Asato R; Shimatsu A
Head Neck; 2013 Dec; 35(12):E363-8. PubMed ID: 23468374
[TBL] [Abstract][Full Text] [Related]
30. Increased RET Activity Coupled with a Reduction in the
Okamoto M; Uesaka T; Ito K; Enomoto H
eNeuro; 2021; 8(3):. PubMed ID: 33958373
[TBL] [Abstract][Full Text] [Related]
31. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
Acton DS; Velthuyzen D; Lips CJ; Höppener JW
Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
33. A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.
Iwashita T; Murakami H; Kurokawa K; Kawai K; Miyauchi A; Futami H; Qiao S; Ichihara M; Takahashi M
Biochem Biophys Res Commun; 2000 Feb; 268(3):804-8. PubMed ID: 10679286
[TBL] [Abstract][Full Text] [Related]
34. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
Arighi E; Popsueva A; Degl'Innocenti D; Borrello MG; Carniti C; Perälä NM; Pierotti MA; Sariola H
Mol Endocrinol; 2004 Apr; 18(4):1004-17. PubMed ID: 14715928
[TBL] [Abstract][Full Text] [Related]
35. Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in vitro, enhances metastatic behavior in vivo, and activates Jun kinase.
Marshall GM; Peaston AE; Hocker JE; Smith SA; Hansford LM; Tobias V; Norris MD; Haber M; Smith DP; Lorenzo MJ; Ponder BA; Hancock JF
Cancer Res; 1997 Dec; 57(23):5399-405. PubMed ID: 9393766
[TBL] [Abstract][Full Text] [Related]
36. New mutations associated with Hirschsprung disease.
Lorente-Ros M; Andrés AM; Sánchez-Galán A; Amiñoso C; García S; Lapunzina P; Solera-García J
An Pediatr (Engl Ed); 2020 Oct; 93(4):222-227. PubMed ID: 34092334
[TBL] [Abstract][Full Text] [Related]
37. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
Pasini B; Rossi R; Ambrosio MR; Zatelli MC; Gullo M; Gobbo M; Collini P; Aiello A; Pansini G; Trasforini G; degli Uberti EC
Surgery; 2002 Apr; 131(4):373-81. PubMed ID: 11935126
[TBL] [Abstract][Full Text] [Related]
38. Ganglioneuromas and renal anomalies are induced by activated RET(MEN2B) in transgenic mice.
Sweetser DA; Froelick GJ; Matsumoto AM; Kafer KE; Marck B; Palmiter RD; Kapur RP
Oncogene; 1999 Jan; 18(4):877-86. PubMed ID: 10023663
[TBL] [Abstract][Full Text] [Related]
39. Allele dosage-dependent penetrance of RET proto-oncogene in an Israeli-Arab inbred family segregating Hirschsprung disease.
Basel-Vanagaite L; Pelet A; Steiner Z; Munnich A; Rozenbach Y; Shohat M; Lyonnet S
Eur J Hum Genet; 2007 Feb; 15(2):242-5. PubMed ID: 17091122
[TBL] [Abstract][Full Text] [Related]
40. Screening of the RET gene of Vietnamese Hirschsprung patients identifies 2 novel missense mutations.
Ngo DN; So MT; Gui H; Tran AQ; Bui DH; Cherny S; Tam PK; Nguyen TL; Garcia-Barcelo MM
J Pediatr Surg; 2012 Oct; 47(10):1859-64. PubMed ID: 23084198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
